| Cord blood CD4+CD25+-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function WR Godfrey, DJ Spoden, YG Ge, SR Baker, B Liu, BL Levine, CH June, ... Blood 105 (2), 750-758, 2005 | 394 | 2005 |
| In vitro–expanded human CD4+ CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell–stimulated MLR cultures WR Godfrey, YG Ge, DJ Spoden, BL Levine, CH June, BR Blazar, ... Blood 104 (2), 453-461, 2004 | 358 | 2004 |
| Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans A Colpan, B Johnston, S Porter, C Clabots, R Anway, L Thao, ... Clinical infectious diseases 57 (9), 1256-1265, 2013 | 227 | 2013 |
| CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy L Li, WR Godfrey, SB Porter, Y Ge, CH June, BR Blazar, VA Boussiotis Blood 106 (9), 3068-3073, 2005 | 198 | 2005 |
| Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen … KL Hippen, P Harker-Murray, SB Porter, SC Merkel, A Londer, DK Taylor, ... Blood, The Journal of the American Society of Hematology 112 (7), 2847-2857, 2008 | 167 | 2008 |
| Intermingled Klebsiella pneumoniae Populations Between Retail Meats and Human Urinary Tract Infections GS Davis, K Waits, L Nordstrom, B Weaver, M Aziz, L Gauld, H Grande, ... Clinical Infectious Diseases 61 (6), 892-899, 2015 | 164 | 2015 |
| Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts R Banerjee, B Johnston, C Lohse, SB Porter, C Clabots, JR Johnson Infection Control & Hospital Epidemiology 34 (4), 361-369, 2013 | 158 | 2013 |
| Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and-negative E. coli clinical … R Banerjee, A Robicsek, MA Kuskowski, S Porter, BD Johnston, ... Antimicrobial agents and chemotherapy 57 (12), 6385-6388, 2013 | 154 | 2013 |
| Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype JR Johnson, SB Porter, G Zhanel, MA Kuskowski, E Denamur Infection and immunity 80 (4), 1554-1562, 2012 | 132 | 2012 |
| Host Characteristics and Bacterial Traits Predict Experimental Virulence for Escherichia coli Bloodstream Isolates From Patients With Urosepsis JR Johnson, S Porter, B Johnston, MA Kuskowski, RR Spurbeck, ... Open forum infectious diseases 2 (3), ofv083, 2015 | 103 | 2015 |
| Household Clustering of Escherichia coli Sequence Type 131 Clinical and Fecal Isolates According to Whole Genome Sequence Analysis JR Johnson, G Davis, C Clabots, BD Johnston, S Porter, C DebRoy, ... Open Forum Infectious Diseases 3 (3), ofw129, 2016 | 81 | 2016 |
| The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011 … JR Johnson, S Porter, P Thuras, M Castanheira Open forum infectious diseases 4 (2), ofx089, 2017 | 76 | 2017 |
| Extensive household outbreak of urinary tract infection and intestinal Colonization due to extended-spectrum β-lactamase–producing Escherichia coli sequence type 131 T Madigan, JR Johnson, C Clabots, BD Johnston, SB Porter, BS Slater, ... Clinical Infectious Diseases 61 (1), e5-e12, 2015 | 71 | 2015 |
| Rapid Emergence, Subsidence, and Molecular Detection of Escherichia coli Sequence Type 1193-fimH64, a New Disseminated Multidrug-Resistant Commensal … JR Johnson, BD Johnston, SB Porter, C Clabots, TL Bender, P Thuras, ... Journal of clinical microbiology 57 (5), 10.1128/jcm. 01664-18, 2019 | 69 | 2019 |
| Clinical and microbiological determinants of infection after transrectal prostate biopsy MA Liss, JR Johnson, SB Porter, B Johnston, C Clabots, K Gillis, U Nseyo, ... Clinical Infectious Diseases 60 (7), 979-987, 2015 | 69 | 2015 |
| Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-H30 (ST131-H30), 2000 to 2009 JR Johnson, S Porter, P Thuras, M Castanheira Antimicrobial agents and chemotherapy 61 (8), 10.1128/aac. 00732-17, 2017 | 55 | 2017 |
| Extraintestinal pathogenic and antimicrobial-resistant Escherichia coli, including sequence type 131 (ST131), from retail chicken breasts in the United States in 2013 JR Johnson, SB Porter, B Johnston, P Thuras, S Clock, M Crupain, ... Applied and Environmental Microbiology 83 (6), e02956-16, 2017 | 54 | 2017 |
| Accessory Traits and Phylogenetic Background Predict Escherichia coli Extraintestinal Virulence Better Than Does Ecological Source JR Johnson, BD Johnston, S Porter, P Thuras, M Aziz, LB Price The Journal of infectious diseases 219 (1), 121-132, 2019 | 53 | 2019 |
| Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli MJ Burgess, JR Johnson, SB Porter, B Johnston, C Clabots, BD Lahr, ... Open forum infectious diseases 2 (1), ofv011, 2015 | 46 | 2015 |
| Activity of cefiderocol, ceftazidime-avibactam, and eravacycline against carbapenem-resistant Escherichia coli isolates from the United States and international sites in … BD Johnston, P Thuras, SB Porter, M Anacker, B VonBank, ... Antimicrobial agents and chemotherapy 64 (10), 10.1128/aac. 00797-20, 2020 | 44 | 2020 |
